Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 15 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 11607414

    Small molecule inhibitors of EGFR and PI3K

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  2. US 11608346

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  3. US 11597727

    Inhibitors of integrin alpha 2 beta 1 and methods of use

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  4. US 11591336

    Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors

    Relay Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  5. US 11591304

    SLC26A3 inhibitors and use thereof

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  6. US 11583538

    Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors

    VENENUM BIODESIGN, LLC · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  7. US 11584733

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  8. US 11584758

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  9. US 11576922

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  10. US 11576948

    Long-acting VEGF inhibitors for intraocular neovascularization

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  11. US 11566007

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  12. US 11560366

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  13. US 11560368

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  14. US 11555041

    Bridged bicyclic inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  15. US 11555055

    Peptide inhibitors of insulin-degrading enzyme

    The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  16. US 11548888

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  17. US 11548899

    Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  18. US 11547687

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  19. US 11542242

    Substituted piperazines as selective HDAC1,2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  20. US 11542261

    Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  21. US 11542275

    Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors

    Aurigene Discovery Technologies Limited · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  22. US 11541045

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  23. US 11534439

    Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  24. US 11534429

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.